Business Context and Reporting Period
This Form 6-K filing by GlaxoSmithKline plc (GSK) covers the month of April 2020, with a specific reporting date of April 14, 2020. The document serves as a transaction notification regarding insider trading activities by Persons Discharging Managerial Responsibilities (PDMRs) and Persons Closely Associated (PCAs) under the Company's Share Reward Plan.
Key Financial Metrics
The filing does not contain consolidated financial statements, revenue, profit, cash flow, margin, debt, or liquidity metrics. It exclusively reports on specific share acquisition transactions.
| Instrument | Transaction Type | Price per Share | Total Volume | Transaction Date | Exchange |
|---|---|---|---|---|---|
| Ordinary Shares (25p) | Acquisition (Share Reward Plan) | £15.3562 | 160 shares (aggregate) | April 9, 2020 | London Stock Exchange |
Note: The aggregate volume of 160 shares represents the sum of 10 individual transactions. Most executives acquired 16 shares (8 partnership + 8 matching), while one executive (Mr. R. Simard) acquired 18 shares (9 partnership + 9 matching).
Material Changes
The filing does not provide comparative financial data or discuss material changes in the company's business operations, financial condition, or results of operations versus prior periods. It strictly documents compliance with disclosure requirements for insider share acquisitions.
Guidance, Outlook, and Risks
The filing contains no management commentary, forward-looking guidance, risk factors, contingencies, or discussion of unusual items. The document is a statutory notification of routine share plan exercises.
Investor Verification Checklist
- Verify the total number of shares acquired by PDMRs and PCAs (160 shares total) against the company's broader insider trading reports.
- Confirm the transaction price of £15.3562 aligns with the market price of GSK ordinary shares on April 9, 2020.
- Review the specific roles of the 10 individuals listed to assess the breadth of executive participation in the Share Reward Plan.
- Note that this filing does not reflect the company's financial performance; refer to Form 20-F or quarterly earnings releases for revenue and profit data.